Oscar Health (NYSE:OSCR) CFO Sells $595,125.00 in Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 18,750 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $31.74, for a total value of $595,125.00. Following the sale, the chief financial officer directly owned 56,250 shares of the company’s stock, valued at $1,785,375. The trade was a 25.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Richard Scott Blackley also recently made the following trade(s):

• On Tuesday, June 2nd, Richard Scott Blackley sold 31,683 shares of Oscar Health stock. The shares were sold at an average price of $21.94, for a total transaction of $695,125.02.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $31.81 on Friday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. The stock has a fifty day simple moving average of $30.03 and a two-hundred day simple moving average of $21.44. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $33.48. The firm has a market cap of $9.82 billion, a price-to-earnings ratio of 22.72, a price-to-earnings-growth ratio of 0.66 and a beta of 2.36.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. The firm had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s revenue was up 70.4% on a year-over-year basis. During the same quarter last year, the company earned ($0.89) earnings per share. Analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Wall Street Analyst Weigh In

OSCR has been the topic of a number of research reports. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Wolfe Research assumed coverage on Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating for the company. Wall Street Zen upgraded Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Weiss Ratings upgraded Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Finally, Robert W. Baird set a $27.00 target price on Oscar Health in a research note on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $26.22.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of OSCR. Thrive Capital Management LLC lifted its holdings in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the period. Baird Financial Group Inc. bought a new position in shares of Oscar Health in the 1st quarter worth approximately $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Oscar Health by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock worth $2,827,000 after acquiring an additional 8,879 shares in the last quarter. Jones Financial Companies Lllp raised its position in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Oscar Health by 39.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock valued at $6,169,000 after purchasing an additional 132,149 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.